Broström L A, Ingimarson S, Strander H, Söderberg G
Acta Orthop Scand. 1980 Aug;51(4):589-94. doi: 10.3109/17453678008990847.
A consecutive series of patients with osteocarcoma have been receiving adjuvant interferon therapy at the Karolinska Hospital in Stockholm. We report here a case of tibial chondroblastic Grade III osteosarcoma, a boy aged 17 years, who received interferon therapy for 15 months and survived more than 5 years. The first sign of tumour spread was multiple cerebral metaseases--an observation suggesting an antitumour effect of human leucocyte interferon on osteosarcoma.
在斯德哥尔摩的卡罗林斯卡医院,一系列骨肉瘤患者一直在接受辅助性干扰素治疗。我们在此报告一例17岁男孩的胫骨III级软骨母细胞性骨肉瘤病例,该男孩接受了15个月的干扰素治疗,存活超过5年。肿瘤扩散的首个迹象是多发性脑转移——这一观察结果提示人白细胞干扰素对骨肉瘤有抗肿瘤作用。